Bioc sec filings

WebApr 5, 2024 · Biocept is filing a notification of late filing on Form 12b-25 with the Securities and Exchange Commission, which provides an automatic 15-day … WebApr 10, 2024 · UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of

Latest SEC filings for Biocept, Inc. (BIOC) Seeking Alpha

WebApr 10, 2024 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Monday, April 10, 2024. Home. SEC Filings. Biocept Inc (BIOC) 8-K Material Event Mon Apr 10 2024; SEC Filings. BIOC Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. BIOC Annual Reports. 10-K … WebFind the latest SEC Filings data for Biocept, Inc. Common Stock (BIOC) at Nasdaq.com. chip shortage a scam https://topratedinvestigations.com

SEC Filing Biocept Inc.

WebNov 14, 2024 · SAN DIEGO (November 10, 2024) – Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results … WebMar 20, 2024 · Key Features. Various SEC filing data available including balance sheets, cash flows and more. Central Index Key (CIK) and ticker conversions for looking up … WebApr 13, 2024 · Millennium Management LLC purchased a new position in shares of Biocept, Inc. ( NASDAQ:BIOC – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 103,124 shares of the medical research company’s stock, valued at approximately $97,000. chip shortage and auto industry

Biocept, Inc. Common Stock (BIOC) SEC Filings Nasdaq

Category:StockNews.com Initiates Coverage on Biocept (NASDAQ:BIOC)

Tags:Bioc sec filings

Bioc sec filings

BIOCEPT INC General Corporate Statement (Form8) - Biocept (NASDAQ:BIOC ...

WebNov 21, 2024 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Monday, November 21, 2024 WebWe would like to show you a description here but the site won’t allow us.

Bioc sec filings

Did you know?

WebSEC Filings for Biocept Inc (BIOC) including Annual 10-K and Quarterly 10-Q Reports. WebMay 24, 2024 · SAN DIEGO (May 23, 2024) – Biocept, Inc.(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results …

WebDec 31, 2024 · This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as … WebNasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia.

WebMar 20, 2024 · Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following … WebApr 9, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of …

WebMay 2, 2024 · These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports …

WebMar 4, 2024 · SEC Filing Biocept Inc. Filed pursuant to Rule 424 (b) (5) Registration No. 333-224946 PROSPECTUS SUPPLEMENT (To Prospectus dated May 24, 2024) Biocept, Inc. 16,000,000 Shares of Common Stock chip shortage cartoonWebApr 12, 2024 · The firm owned 175,500 shares of the medical research company’s stock after purchasing an additional 59,100 shares during the quarter. Renaissance Technologies LLC owned 1.04% of Biocept worth... graphe en pythonWebApr 10, 2024 · SEC Filing Biocept Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 BIOCEPT, INC. (Exact name of registrant as … graphe facileWebMay 12, 2024 · Ticker: BIOC CIK: 1044378 Form Type: 8-K Corporate News Accession Number: 0001564590-21-027005 Submitted to the SEC: Wed May 12 2024 4:14:46 PM … graphed notebookWebBiocept Inc. SEC filings breakout by MarketWatch. View the BIOC U.S. Securities and Exchange Commission reporting information. chip shortage coming to endWebMay 12, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities … chip shortage computersWebApr 6, 2024 · Biocept GAAP EPS of -$0.04 beats by $0.27, revenue of $5.59M misses by $2.27M SA NewsMon, Nov. 21, 2024 Biocept, Inc. SEC Filing - Quarterly Report (10-Q) November 21, 2024 SEC FilingsMon,... chip shortage dealership